Physician
Zganjar, Brian
Zganjar, Brian was paid $2.44M by Medicaid between Jan 2018 and Mar 2020, across 78 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 43% of everything it billed.
33Billing provider infoZGANJAR, BRIAN
DENHAM SPRINGS, LA 70726
DENHAM SPRINGS, LA 70726
33aNPI1174559470assigned 06/25/2006
33bProvider typePediatrics Physician
28Total paid$2.44M
24GClaims89,364
24DCodes billed78
24AFirst – last monthJan 2018 – Mar 2020
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#50 of 230
Median peer was paid$429K
This provider vs. median5.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,075 | $1.17M | |
| 2019 | 40,169 | $1.13M | |
| 2020 | 5,120 | $149K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 43% | 15,865 | 13,359 | $1.05M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 10,396 | 8,686 | $455K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.9% | 2,294 | 2,107 | $144K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.7% | 1,814 | 1,739 | $116K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.7% | 1,981 | 1,853 | $115K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.3% | 4,154 | 3,786 | $105K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.7% | 1,255 | 1,199 | $89K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.2% | 5,873 | 5,439 | $78K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.0% | 3,428 | 3,216 | $48K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.6% | 3,234 | 2,949 | $38K |
| 99381 | 1.4% | 508 | 482 | $35K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,084 | 1,011 | $24K |
66 more codes
| 99188 | <1% | 1,143 | $17K | |
| 92551 | <1% | 2,197 | $16K | |
| 99051 | <1% | 1,148 | $16K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 183 | $12K |
| 17110 | <1% | 189 | $12K | |
| 90474 | <1% | 1,205 | $10K | |
| 83655 | <1% | 853 | $9K | |
| 99383 | <1% | 85 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 59 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 127 | $4K |
| 99499 | <1% | 496 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 528 | $4K |
| 87807 | <1% | 298 | $4K | |
| 99177 | <1% | 3,070 | $4K | |
| 99382 | <1% | 42 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 29 | $3K |
| 99384 | <1% | 25 | $2K | |
| 85018 | <1% | 867 | $2K | |
| 81025 | <1% | 262 | $1K | |
| 81003 | <1% | 738 | $1K | |
| 99050 | <1% | 82 | $972.24 | |
| 69210 | <1% | 40 | $819.00 | |
| 90473 | <1% | 99 | $803.11 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 70 | $747.40 |
| 17250 | <1% | 12 | $572.77 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 127 | $320.00 |
| 96160 | <1% | 65 | $247.13 | |
| 99173 | <1% | 123 | $196.00 | |
| 94760 | <1% | 1,159 | $111.33 | |
| 90734 | <1% | 615 | $90.68 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 28 | $56.82 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 72 | $50.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 31 | $47.98 |
| 90647 | <1% | 276 | $32.58 | |
| 90715 | <1% | 392 | $30.95 | |
| 36416 | <1% | 1,640 | $20.24 | |
| 96127 | <1% | 24 | $18.75 | |
| 90688 | <1% | 43 | $17.84 | |
| 90680 | 0% | 1,210 | $0.00 | |
| 3074F | 0% | 377 | $0.00 | |
| 90744 | 0% | 912 | $0.00 | |
| 90696 | 0% | 319 | $0.00 | |
| 90716 | 0% | 250 | $0.00 | |
| 90651 | 0% | 697 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 552 | $0.00 |
| 90698 | 0% | 1,288 | $0.00 | |
| 90686 | 0% | 1,473 | $0.00 | |
| G8422 | Bmi not documented, documentation the patient is not eligible for bmi calculation | 0% | 6,579 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 49 | $0.00 |
| 90620 | 0% | 84 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 28 | $0.00 |
| 3008F | 0% | 14 | $0.00 | |
| 90723 | 0% | 12 | $0.00 | |
| 90621 | 0% | 54 | $0.00 | |
| 90633 | 0% | 1,169 | $0.00 | |
| 90670 | 0% | 1,763 | $0.00 | |
| 90710 | 0% | 548 | $0.00 | |
| 3078F | 0% | 209 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 109 | $0.00 |
| G8421 | Bmi not documented and no reason is given | 0% | 90 | $0.00 |
| 90700 | 0% | 301 | $0.00 | |
| 90685 | 0% | 464 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 148 | $0.00 |
| 80061 | Lipid panel | 0% | 72 | $0.00 |
| 90707 | 0% | 162 | $0.00 | |
| 90672 | 0% | 103 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.